Maternal Hyperglycemia Not Linked to Obesity in Offspring

This article originally appeared here.
Share this content:
Maternal Hyperglycemia Not Linked to Obesity in Offspring
Maternal Hyperglycemia Not Linked to Obesity in Offspring

MONDAY, June 29, 2015 (HealthDay News) -- Maternal hyperglycemia seems not to be a risk factor for obesity in offspring aged 5 to 7 years after adjustment for maternal body mass index (BMI), according to a study published online June 19 in Diabetes Care.

Parag K. Thaware, from the Royal Victoria Hospital in Belfast, U.K., and colleagues examined the correlation between hyperglycemia during pregnancy and anthropometry in 5- to 7-year-old offspring. Women underwent a 75-gram oral glucose tolerance test (OGTT) at about 28 weeks of gestation. Overall, 1,320 offspring underwent weight, height, and skinfold thickness measures at age 5 to 7 years.

The researchers found that there was no correlation for maternal fasting plasma glucose (FPG), one-hour plasma glucose, or two-hour plasma glucose with BMI Z score or offspring skinfold sum independent of maternal BMI at OGTT and offspring birth weight Z score. With the offspring BMI Z score expressed as ≥85th, ≥95th, or 99th percentile and the sum of skinfolds expressed as ≥90th percentile specific for sex, this lack of correlation with maternal glycemia persisted. Maternal BMI at OGTT accounted for the initially significant relation between FPG and all offspring adiposity measures.

"After adjustment for maternal BMI at the OGTT, higher maternal FPG concentration during pregnancy (short of diabetes) is no longer a risk factor for obesity, as reflected by BMI and the sum of skinfolds in offspring aged 5 to 7 years," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »